-
-
-
-
-
-
-
Marinus Pharma (MRNS) Announces FDA Acceptance for Filing and Priority Review of New Drug Application for Ganaxolone in CDKL5 Deficiency Disorder
-
-
-
-
-
-
-
Marinus Pharma' (MRNS) Ganaxolone IV to Treat Status Epilepticus Receives FDA Orphan Drug Designation
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

